At a time when the coronavirus is convulsing again with out of proportion new cases in the state, there are few doctors from AYUSH amplifying their support to arrest the spread of coronavirus through carrying out clinical trials on Broad-Spectrum Antiviral Prophylactic Medicine (BSAPM – Unani), an Indian way of treatment that helps boosting immunity system and even getting upbeat results.
The clinical trials on “Broad Spectrum Antiviral Prophylactic Medicine (BSAPM), said to have been helping people in boosting their immunity widely considered as most essential component to fight the contagion, has taken up by Dr. Mujtaba Ali Hashmi, BUMS (Osm) & M.D (Gyn. & Obs) who claimed to have been working on the subject for years.
ALSO READ: Second Wave of Coronavirus Affects Infants in Delhi; Report
Dr.Hashmi’s, who is also a Chairman of Dr.Hashmi’s Unani Medicine Observation and Research Foundation Hyderabad, said that “The literature in Unani system of medicine show the use of Broad-Spectrum Antiviral Prophylactic Medicine (BSAPM) to induce immunity and herd immunity against various types of virus-infected diseases. The ancient empirical evidence proves that the herd immunity through administration of BSAPM shown that the pandemic called the “Anthonine Plaque” of 165 to 180 AD (Plaque of Galen) was successfully eradicated. Thus, there is a need to take a scientific study of BSAPM (Unani) to prevent the spread of novel coronavirus.”
His research, he further said, is solely focused on improving the immune system in the human body to allow people to develop a strong immunity that would help them fight the seasonal diseases and even contagion alike. “We have taken up research work on Broad-Spectrum Antiviral Prophylactic Medicine (Unani system of treatment) to boost immunity and herd immunity in order to arrest the spread of the novel coronavirus,” he explained. The research paper of Dr.Hashmi, was already published on 19th May 2020 and widely viewed by researchers across the globe.
Claiming that the clinical trials on Broad-Spectrum Antiviral Prophylactic Medicine (BSAPM – Unani) is yielding good results, he said, “So far 100 subjects gone through the clinical trials whom we have administered oral medicine in the form of tablets i.e. one tablet each before food in morning and night. The doses were administered to the age group of 9 to 80 years.”
ALSO READ: Coronavirus RNA Found In Dust of Isolation Centers
After getting registered with the Clinical Trials Registry, India (CTRI), ICMR – National Institute of Medical Statistics recently, Dr.Hashmi took up his research work and have come across with encouraging response of his preventive medicine on subjects. “During the trial it was observed that the immunity level of the subjects have improved and this medicine is targeting spike proteins which is a primary cause of multiplying the virus in the host subject. There are a total 100 subjects gone through the trial without any adverse effect of the oral medicine administered to them,” claimed Dr.Hashmi.
